Nijland, Hanneke M J <br/><br/>
High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.  [electronic resource] 

 -  AIDS (London, England)  May 2008 
 - 931-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0b013e3282faa71e  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alanine Transaminase--blood<br/>Antibiotics, Antitubercular--adverse effects<br/>Aspartate Aminotransferases--blood<br/>Drug Administration Schedule<br/>Drug Combinations<br/>Drug Interactions<br/>Female<br/>HIV Protease Inhibitors--administration & dosage<br/>Humans<br/>Lopinavir<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Pyrimidinones--administration & dosage<br/>Rifampin--administration & dosage<br/>Ritonavir--administration & dosage<br/>Tablets<br/>Vomiting--chemically induced